CLINICAL TRIALS PROFILE FOR LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER
✉ Email this page to a colleague
All Clinical Trials for Lidocaine Hydrochloride Preservative Free In Plastic Container
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00468429 ↗ | Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery | Unknown status | Grewal Eye Institute | Phase 4 | 2007-05-01 | This study analyzes the safety and efficacy of off-label Subconjunctival Injection of bevacizumab (Avastin) versus 0.02% mitomycin C (MMC) for preventing bleb failure following glaucoma filtration surgery. |
| NCT00948103 ↗ | The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A | Completed | Assistance Publique - Hôpitaux de Paris | Phase 3 | 2008-09-01 | Second line treatment for detrusor hyperreflexia is the intravesical BTX-A injections. First 300 units Botox are diluted with 30 ml of preservative-free saline. Using a rigid cystoscope and an injection needle, BTX-A is injected into 30 sites within the detrusor muscle. The used of KALINOX® (50% nitrous oxide and oxygen) inhalation has demonstrated analgesic efficacy in various procedures (obstetric, liver biopsy, transrectal ultrasound guided prostate biopsy, emergency) The aim of this study is to investigate the safety and efficacy of analgesia with N2O/O2 inhalation for detrusor BTX-A injections using a rigid cystoscope. |
| NCT01905137 ↗ | Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain | Unknown status | Allergan | N/A | 2013-07-01 | The purpose of this study is to determine whether there is a change in patient-reported pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of normal saline. |
| NCT01905137 ↗ | Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain | Unknown status | Boston Urogynecology Associates | N/A | 2013-07-01 | The purpose of this study is to determine whether there is a change in patient-reported pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of normal saline. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Lidocaine Hydrochloride Preservative Free In Plastic Container
Condition Name
| Condition Name for Lidocaine Hydrochloride Preservative Free In Plastic Container | |
| Intervention | Trials |
| Pain | 2 |
| Injection Site Vesicles | 1 |
| Peripheral Neuropathy Due to Chemotherapy | 1 |
| Dry Eye Syndromes | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Condition MeSH
Clinical Trial Locations for Lidocaine Hydrochloride Preservative Free In Plastic Container
Trials by Country
Clinical Trial Progress for Lidocaine Hydrochloride Preservative Free In Plastic Container
Clinical Trial Phase
Clinical Trial Sponsors for Lidocaine Hydrochloride Preservative Free In Plastic Container
Sponsor Name
